Home
Market Capitalization of Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals Ltd
NSE: APLLTD
Market Cap
Key Highlights
- The Market Cap of Alembic Pharmaceuticals Ltd is ₹ 15779 crore as of 21 Feb 25 .
- The Latest Trading Price of Alembic Pharmaceuticals Ltd is ₹ 802.75 as of 21 Feb 15:30 .
- The dividend payouts of Alembic Pharmaceuticals Ltd changed from ₹ 7 to ₹ 11 over 6 quarters. This represents a CAGR of 35.16% .

Alembic Pharmaceuticals Ltd
NSE: APLLTD
Share Price
Market Price of Alembic Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 802.75 |
20 Feb 2025 | 813.3 |
19 Feb 2025 | 812.45 |
18 Feb 2025 | 810.45 |
17 Feb 2025 | 814 |
14 Feb 2025 | 818.1 |
13 Feb 2025 | 826.2 |
12 Feb 2025 | 845.2 |
11 Feb 2025 | 868.95 |
10 Feb 2025 | 885.45 |
SWOT Analysis Of Alembic Pharmaceuticals Ltd
BlinkX Score for Alembic Pharmaceuticals Ltd
Asset Value vs Market Value of Alembic Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Alembic Pharmaceuticals Ltd
Historical P/E Ratio of Alembic Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Alembic Pharmaceuticals Ltd
Historical Revenue of Alembic Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Alembic Pharmaceuticals Ltd
Historical EBITDA of Alembic Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Alembic Pharmaceuticals Ltd
Historical Net Profit of Alembic Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Alembic Pharmaceuticals Ltd
Historical Dividend Payouts of Alembic Pharmaceuticals Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Alembic Pharmaceuticals Ltd
About Alembic Pharmaceuticals Ltd
- Alembic Pharmaceuticals manufactures and markets generic pharmaceutical products all over the world.
- The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Ltd was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Ltd. The company is engaged in pharmaceuticals business.
- As per the scheme of arrangement, the 'Pharmaceutical Undertaking' of the Alembic Ltd was demerged and transferred to the company with effect from appointed date, April 1, 2010. In April 15, 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement.
Alembic Pharmaceuticals Ltd News Hub
Alembic Pharma receives USFDA approval for Dabigatran Etexilate Capsules
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) f
Read more
13 Aug 24
Alembic Pharma gets US FDA nod for anticoagulant Dabigatran
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Pradaxa
Read more
13 Aug 24
Alembic Pharmaceuticals Ltd leads losers in 'A' group
Steel Authority of India Ltd, IFCI Ltd, Coffee Day Enterprises Ltd and Orient Cement Ltd are among t
Read more
09 Aug 24
Alembic Pharma Q1 PAT rises 12% YoY to Rs 135 cr
Revenue from operations grew 5.09% year on year (YoY) to Rs 1,561.73 crore in the quarter ended 30 J
Read more
08 Aug 24